RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. by Lee, Cha-Ze et al.
JOURNAL OF VIROLOGY, Apr. 1993, P. 2221-2227
0022-538X193/042221-07$02.00/0
Copyright © 1993, American Society for Microbiology
RNA-Binding Activity of Hepatitis Delta Antigen Involves Two
Arginine-Rich Motifs and Is Required for Hepatitis
Delta Virus RNA Replication
CHA-ZE LEE,1 JU-HUNG LIN,1 MEI CHAO,' KEVIN McKNIGHT,2 AND MICHAEL M. C. LAI`*
Howard Hughes Medical Institute and Department ofMicrobiology, University of Southern California
School ofMedicine, Los Angeles, California 90033-1054,1 and Department ofMicrobiology,
University ofNorth Carolina, Chapel Hill, North Carolina 27599-72902
Received 31 July 1992/Accepted 20 January 1993
Hepatitis delta antigen (HIAg) is an RNA-binding protein with binding specificity for hepatitis delta virus
(HDV) RNA (J. H. Lin, M. F. Chang, S. C. Baker, S. Govindarajan, and M. M. C. Lai, J. Virol.
64:4051-4058, 1990). By amino acid sequence homology search, we have identified within its RNA-binding
domain two stretches of an arginine-rich motif (ARM), which is present in many prokaryotic and eukaryotic
RNA-binding proteins. The first one is KERQDHRRRKA and the second is EDEKRERRIAG, and they are
separated by 29 amino acids. Deletion of either one of these ARM sequences resulted in the total loss of the in
vitro RNA-binding activity of HDAg. Thus, HDAg is different from other RNA-binding proteins in that it
requires two ARM-like sequences for its RNA-binding activity. Replacement of the spacer sequence between
the two ARMs with a shorter stretch of sequence also reduced RNA binding in vitro. Furthermore, site-specific
mutations of the basic amino acid residues in both ARMs resulted in the total loss or reduction of RNA-binding
activity. The biological significance of the RNA-binding activity was studied by examining the trans-activating
activity of the RNA-binding mutants. The plasmids expressing HDAgs with various mutations in the
RNA-binding motifs were cotransfected with a replication-defective HDV dimer cDNA construct into COS
cells. It was found that all the HDAg mutants which had lost the in vitro RNA-binding activity also lost the
ability to complement the defect of HDV RNA replication. We conclude that the trans-activating function of
HDAg requires its binding to HDV RNA.
Hepatitis delta virus (HDV) is a satellite virus of hepatitis
B virus and is an etiological agent of certain severe forms of
viral hepatitis (32). HDV contains a single-stranded circular
RNA genome of 1.7 kb in length (21, 30, 38), which has
extensive intramolecular complementary sequences. Its
RNA structure resembles that of viroids, virusoids, and
plant satellite virus RNAs. HDV RNA has an autocatalytic
cleavage and ligation activity (23, 35, 36, 40-42), and appears
to replicate by a rolling-circle mechanism (10, 29). It has
been shown that HDV RNA replication requires the pres-
ence of a virus-encoded protein, hepatitis delta antigen
(HDAg) (22). However, the molecular mechanism by which
HDAg participates in HDV RNA replication is not clear.
HDAg is a phosphoprotein (6) and usually consists of two
protein species of 24 kDa (small HDAg, 195 amino acids) and
27 kDa (large HDAg, 214 amino acids) (3, 39). These two
proteins are identical in sequence, but the large HDAg
contains 19 additional amino acids at the carboxyl terminus
(39). The small HDAg is required for HDV RNA replication
(22), while the large one inhibits RNA replication (7, 14) and
is required for HDV assembly (5, 33). Both HDAgs are
localized in the nuclei of HDV-infected cells (27, 44). We
have previously shown that HDAg binds specifically to HDV
RNA (26). This binding requires a specific RNA structure,
rather than specific sequences, of HDV RNA (7, 26). The
RNA-binding sites on HDAg have been mapped within the
middle one-third region of HDAg (amino acids 79 to 163)
(26). Both the large and small HDAg bind to HDV RNA at
equal efficiency (20). However, the molecular basis and
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functional significance of RNA binding by HDAg are not
clear.
Two classes of prokaryotic and eukaryotic RNA-binding
proteins have previously been identified. One contains RNA
recognition motif, which consists of 80 amino acids with two
conserved sequences, RNP-1 and RNP-2, of 8 and 6 amino
acids, respectively (1, 31). This class of RNA-binding pro-
teins includes proteins which bind to pre-mRNA, mRNA,
small nuclear RNA, and pre-rRNA and are involved in the
regulation of translation, splicing, and a variety of other
activities (1, 31). The other class contains an arginine-rich
motif (ARM) with a core of 4 to 8 amino acids, mostly
arginines (25). The ARM sequence itself is sufficient for
specific RNA recognition. The tat and rev proteins of human
immunodeficiency virus type 1 (HIV-1), the N protein of
bacteriophage lambda, and the capsid proteins of some RNA
viruses belong to this family (25). In this report, we have
demonstrated that HDAg contains two ARM-like sequences,
both of which are required for RNA binding. Alteration of
either ARM sequence diminished the RNA-binding activity.
Thus, HDAg represents a new class of RNA-binding protein.
Furthermore, the RNA-binding activity ofHDAg is required
for its trans-activating activity for HDV RNA replication,
suggesting that HDAg functions by binding to HDV RNA.
MATERIALS AND METHODS
Computer analysis of HDAg sequence. The HDAg se-
quence of the Southern California isolate of HDV (30) was
used for sequence analysis using the BESTFIT program
from the Genetics Computer Group (University of Wiscon-
sin, Madison). Optimal alignment of sequences was made by
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FIG. 1. Schematic diagram of the construction of HDV dimer mutant Smd2 and the relevant restriction enzyme sites. The thick arrow
represents HDV monomer sequences of genomic sense. The thin arrow represents the HDAg-coding region, which is on the antigenomic
orientation. The thin line represents PECE vector sequence (13).
using the local homology algorithm of Smith and Waterman
(37).
Construction of plasmids. All of the constructs were made
from the cDNA clones of Southern California isolate of
HDV RNA (30). HDAg-truncated mutant plasmids L6 and
L14 were derived from pATH-M (26), which encodes the
middle one-third (amino acids 79 to 163) of HDAg fused to
the TrpE protein of Escherichia coli, by the exonuclease
digestion method developed by Henikoff (17). For construc-
tion of plasmids WD and L10, the full-length and the
C-terminal two-thirds (amino acids 108 to 214) of the HDAg-
coding region, respectively, were made by polymerase chain
reaction to amplify HDAg sequences of the desired regions
by using two oligonucleotide primers which contained the
appropriate HDV sequences plus BamHI and HindIII linker
sequences. The cDNA products were then inserted into
pATH-2 polycloning sites (12). For construction of plasmid
D1-2, two cDNAs encoding amino acids 1 to 109 and 136 to
214 of HDAg and containing XbaI site at both ends were
made by polymerase chain reaction and inserted into
pATH-2. The HDAg-coding sequences in Al, A2, and A2'
were made by polymerase chain reaction using the method
described by Higuchi et al. (18) and inserted into pATH-2
polycloning sites BamHI and HindIII.
The replication-defective HDV dimer construct, Smd2,
which was used for the testing of the trans-acting activity of
the HDAg mutants, was constructed by cloning a head-to-
tail dimer of full-length HDV cDNA (30) into the Sall site of
the PECE vector, which contains a simian virus 40 T-antigen
promoter (13). The resulting plasmid was digested into two
fragments withAflII; both of the fragments were blunt ended
with nuclease S1 and religated (Fig. 1). As a result, a deletion
of 4 nucleotides and a frameshift were introduced at the site
corresponding to amino acid 130 of the HDAg-coding region.
This plasmid transcribed a replication-defective HDV dimer
RNA, which could replicate only when a wild-type HDAg
was supplied. PECE-Sm, which expresses a wild-type small
HDAg, was made by inserting the EcoRI-BamHI fragment
of the HDV cDNA encoding the small HDAg into the EcoRI
and BglII sites of the PECE vector. Other plasmids express-
ing various HDAg mutants, including PECE-Al, PECE-A2,
PECE-A2', and PECE-D1-2, were made by replacing the
StuI-SmaI fragment of PECE-Sm with the corresponding
fragments from Al, A2, A2', and D1-2, respectively. The
sequences of the resulting plasmids were confirmed by
dideoxyribonucleotide chain termination sequencing (34).
Preparation of TrpE-HDAg fusion proteins. Bacteria were
grown by previously published procedures (26). Briefly,
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cultures of E. coli MC1061 cells transformed with plasmids
encoding different TrpE-HDAg mutant fusion proteins were
induced with 3-indoleacrylic acid (40 ,ug/ml) for 3 h. Bacteria
were lysed by digesting with lysozyme (1 mg/ml) and re-
peated freeze-thawing. The lysates were further digested
with DNase I. The fusion proteins were collected in the
insoluble fraction and resuspended in a buffer containing
0.01 M sodium phosphate (pH 7.2), 0.1% ,3-mercaptoetha-
nol, 1% sodium dodecyl sulfate (SDS), and 6 M urea as
previously described (26).
Immunoblot and RNA-protein blot procedures. TrpE-
HDAg fusion proteins were separated by SDS-polyacryl-
amide gel electrophoresis (PAGE) (7.5% polyacrylamide)
and electrotransferred to nitrocellulose membranes. For
immunoblot analysis, the membranes were first incubated
with 5% nonfat milk and then with anti-HDAg antibody (26)
followed by 125I-labeled protein A according to the published
procedures (9). For RNA-protein blot (Northwestern) anal-
ysis, the membranes were incubated in standard binding
buffer (SBB; 10mM Tris-HCl [pH 7.4], 1 mM EDTA, 50mM
NaCl, 0.02% bovine serum albumin, 0.02% Ficoll, and
0.02% polyvinylpyrrolidone) containing 10 ,ug of yeast trans-
fer RNA per ml and 100 ,ug of cellular RNA from DBT cells
per ml for 1 h and then incubated with 32P-labeled HDV
genomic RNA in the same buffer for another hour according
to the published procedures (26). After washing three times
with SBB at room temperature for 15 min each, the mem-
branes were exposed to X-ray films.
RNA mobility shift assay. RNA mobility shift assay was
carried out as previously described (26). Briefly, 20 ,ug of
partially purified TrpE-HDAg proteins was incubated with
10 ng of 32P-labeled HDV genomic RNA in 10 ,ul of buffer
containing 2.5 mM Tris-HCl (pH 7.4), 100 mM NaCl, 2 mM
MgCl2, 1 mM dithiothreitol, and 20% glycerol with 40 U of
RNasin (Promega), 10 ,ug of tRNA, and 10 ,ug of total cellular
RNA at 37°C for 30 min. After incubation, the samples were
directly analyzed by electrophoresis under nondenaturing
conditions. Electrophoresis was carried out on a 0.6% low-
melting agarose gel at 25 V for 15 h at 4°C (26). After
electrophoresis, the gel was dried and visualized by autora-
diography.
DNA transfection. COS 7 cells (16) at 50% confluency in
6-cm petri dishes were incubated with 5 p,g of PECE
plasmids containing replication-defective HDV dimer DNA,
plasmids encoding either the wild-type or mutant small
HDAg, and 25 ,ug of Lipofectin (Bethesda Research Labo-
ratories) for 12 h. The cells were washed with Dulbecco
modified Eagle medium (DMEM) and then incubated with
DMEM containing 5% fetal calf serum for another 5 days.
The total cellular RNA was then extracted by acid guanidi-
nium isothiocyanate (11) at 6 days posttransfection. The
RNA was analyzed by Northern blot analysis using 32p_
labeled anti-genomic HDV RNA as a probe (43).
RESULTS
RNA-binding motifs of HDAg. To identify the amino acid
residues responsible for the RNA binding of HDAg, we first
searched for the presence of the known RNA-binding motifs
in HDAg. Since the RNA-binding region is located within
the middle one-third domain (amino acids 79 to 163) of
HDAg (26), we examined whether this region contained an
RNA recognition motif or an ARM. No RNA recognition
motif was found in this region. However, two stretches of
amino acid sequences have different degrees of similarity







1st ARM of HDAg (aa 97-107)
2nd ARM of HDAg (aa 136-146)




FIG. 2. Conserved ARMs in representative RNA-binding pro-
teins. Abbreviations: B, basic; 0, nonbasic polar; Z, charged; and J,
acidic amino acids; HIV, human immunodeficiency virus. Part of
the data are from reference 25.
KERQDHRRRKA (from amino acids 97 to 107), and the
second was EDEKRERRIAG (from amino acids 136 to 146)
(Fig. 2). The presence of two stretches of ARM-like se-
quences in the same protein is unique among the known
RNA-binding proteins.
RNA-protein-binding assays of HDAg deletion mutants. To
determine whether either of the ARM-like sequences was
involved in RNA binding, we made a series of deletion
mutants starting from the C-terminal end of the middle
domain (M) of HDAg (amino acid residues 89 to 163), which
includes the necessary and sufficient RNA-binding se-
quences (26). These mutants were expressed in E. coli as
TrpE fusion proteins. The partially purified fusion proteins
were separated by SDS-PAGE, transferred to nitrocellulose
filter membrane, and incubated with 32P-labeled HDV
genomic RNA by a Northwestern procedure, under condi-
tions shown to allow specific binding between HDAg and
HDV RNA (6, 26). Among these deletion mutants, L6
contains the longest HDAg sequence (amino acid residues 89
to 143) and was found to bind HDV RNA (Fig. 3B). Further
truncation at the C-terminal end resulted in the complete loss
of the RNA-binding activity. For examples, mutant L14
(amino acids 89 to 135) and smaller mutants did not bind
HDV RNA (Fig. 3B and data not shown) when the same
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FIG. 3. RNA-protein binding assays of the HDAg deletion mu-
tants. The various TrpE-HDAg fusion proteins were separated by
SDS-PAGE, electrotransferred to nitrocellulose membranes, and
incubated with an anti-HDAg antibody for the quantitation of the
fusion proteins by immunoblot analysis (A) or incubated with
32P-labeled HDV genomic RNA for RNA-binding assays by North-
western blot analysis (B) as described in Materials and Methods.
The schematic diagram of the structures of the TrpE-fusion proteins
is shown above. The molecular mass markers (in kilodaltons) are
indicated. The shaded areas represent the ARM-like sequences.
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FIG. 4. RNA-protein binding assays of the site-specific mutants
of the HDAg ARM sequences. The different TrpE-HDAg fusion
proteins were separated by SDS-PAGE, electrotransferred to nitro-
cellulose membranes, and incubated with anti-HDAg antibody for
immunoblot analysis (A) or incubated with 32P-labeled HDV
genomic RNA for Northwestern blot analysis (B). The schematic
diagram of the structures of the TrpE-fusion proteins is shown
above. The molecular mass markers (in kilodaltons) are indicated.
The mutated ARM sequences are identified by lighter shaded boxes,
and the substituted amino acids are indicated.
amounts of the various fusion proteins were used (Fig. 3A).
Thus, residues 135 to 143 appear to contain sequences
necessary for HDV RNA binding. This stretch of sequences
corresponds to a major portion of the second ARM-like
sequence (Fig. 2). To delineate the contribution of the first
ARM, another mutant, L10, which spans amino acids 108 to
214 and contains only the second ARM but not the first, was
constructed. This protein did not bind HDV RNA (Fig. 3B).
Thus, mutants without either the first or second ARM
showed no binding to HDV RNA. This result indicates that
the both ARMs of HDAg are necessary for RNA binding.
The importance of the spacer region between the two ARMs
was addressed by another mutant, D1-2, in which the entire
spacer sequence (residues 108 to 135) was replaced with four
irrelevant amino acids (Leu, Ala, Ser, and Arg). This mutant
retained only a small fraction (approximately 5% of the
wild-type protein) of the RNA-binding activity (Fig. 3B).
Thus, the spacer sequence between the two ARMs is also
important for the RNA binding.
RNA-protein-binding assays of site-specific mutants. The
importance of the both ARM-like sequences in RNA binding
was further assessed by site-specific mutagenesis of these
sequences. Three mutants, Al (Arg-104 and Arg-105;
changed to Gln and Gly, respectively), A2 (Arg-142 and
Arg-143; changed to Ser and Gly, respectively), and A2'
(Lys-139, changed to Asn, and Arg-140, changed to Gly)
were made on the full-length HDAg-TrpE fusion protein.
Their RNA-binding activities were examined by Northwest-
ern blot with 32P-labeled HDV genomic RNA. The same
amounts of the fusion proteins were used for each mutant, as
evidenced by immunoblot analysis (Fig. 4A). The result
showed that the substitutions of Arg in the first ARM (Al)
completely eliminated the RNA-binding activity (Fig. 4B).
The effects of mutations in the second ARM were more
variable. A2', which had substitutions of the first Lys and
FIG. 5. RNA mobility shift analysis of the arginine mutants of
the two ARMs. Different mutant HDAg proteins as described in the
legend to Fig. 4 were incubated with 32P-labeled HDV genomic RNA
and separated by electrophoresis on 0.6% low-melting-point agarose
gels under nondenaturing conditions (26). P, HDV RNA. Arrows
indicate the free RNA and RNA-protein complexes.
Arg, had a 10-fold-lower binding activity than the wild-type
HDAg. In contrast, A2, which had substitutions of the two
downstream arginines, had a fourfold lower binding activity
(Fig. 4B). The specificity of this binding assay has previously
been demonstrated by competition with the excess cold
RNA (26). The RNA-binding activities of the mutant HDAgs
were further examined by RNA mobility shift assays (Fig.
5). The results showed that the wild-type HDAg and A2
mutant protein formed an RNA-protein complex with HDV
genomic RNA. In contrast, only negligible amounts of Al or
A2' mutants formed the RNA-protein complex with HDV
RNA under the same conditions. Again, the specificity of
this assay has previously been demonstrated (26). Thus, the
two upstream basic amino acids in the second ARM-like
sequence are more important than the downstream ones for
the RNA binding. These studies indicated that both of the
ARM-like sequences are necessary for the RNA-binding
activity of HDAg.
Biological significance of the RNA-binding activity of
HDAg. To determine the biological significance of the RNA-
binding activity of HDAg, we examined whether the RNA-
binding activity of HDAg was required for its trans-acting
activity for HDV RNA replication (22). We constructed a
plasmid expressing a defective HDV dimer which had a
frameshift mutation in the HDAg-coding region. When this
plasmid was transfected into COS 7 cells, very little HDV
monomer RNA was detected, indicating that this plasmid
could not replicate (Fig. 6, lane Smd2). However, when this
construct was cotransfected with a plasmid (PECE-Sm)
expressing a wild-type small HDAg, an HDV monomer
RNA could be detected (Fig. 6, lane Sm), suggesting that
HDAg could activate RNA replication in trans. This result
was in agreement with the published finding that HDAg is
required for HDV RNA replication (22). When the HDV
dimer construct was cotransfected with the different plas-
mids expressing an HDAg with various mutations in the
RNA-binding motif, only mutant A2, which retained most of
the in vitro RNA-binding activity, could restore the RNA
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FIG. 7. Schematic diagram of the functional domains of HDAg.
FIG. 6. Analysis of the trans-activating activity of mutant
HDAgs with a defective HDV dimer and mutant HDAg-expressing
plasmids. COS 7 cells were cotransfected with HDV dimer DNA
(Smd2) and various mutant HDAg DNA as described in Results.
Cellular RNA was extracted 6 days posttransfection, separated in
formaldehyde gels, transferred to nylon membrane, and incubated
with 32P-labeled HDV antigenomic-sense (A) or genomic-sense (B)
RNA. The membrane was also incubated with 32P-labeled ribosomal
RNA (lower panels) for the quantitation of RNA. The arrow
indicates monomeric HDV genomic RNA. HIb9 is an HDV stably
transformed COS 7 cell line which serves as a size marker for
monomer HDV RNA. All constructs are in PECE plasmid with the
simian virus 40 early promoter (13).
similar when either the wild-type HDAg or A2 mutant was
used. The remaining mutants, Al, A2', and D1-2, which had
no or only minimal RNA-binding activities, did not comple-
ment the defects of replication of Smd2 RNA (Fig. 6A). This
result was confirmed by the relative amounts of antigenomic
RNA synthesized in cells transfected with Smd2 and the
different HDAg mutants (Fig. 6B), while the amounts of
RNA used for Northern blot analysis were shown to be the
same for all of the samples. We thus conclude that the
RNA-binding activity is crucial for the trans-activating ac-
tivity of HDAg.
DISCUSSION
HDAg is an RNA-binding protein with a binding specific-
ity for HDV RNA (26). The results presented in this report
showed that the RNA-binding properties of HDAg require
two stretches of the ARM-like sequence working in concert.
Furthermore, a spacer sequence separating the two ARM-
like sequences also contributes to the binding activity.
Although the ARM-like sequence has previously been de-
tected in several prokaryotic and eukaryotic RNA-binding
proteins (25), this is the first protein shown to require two of
these sequences for RNA binding. Thus, HDAg likely rep-
resents a new type of RNA-binding protein which has a
unique specificity for HDV RNA sequence or structure. We
have previously shown that HDAg binds specifically to HDV
RNA but not to other viral or cellular RNA (26). The binding
specificity appears not to be dependent on nucleotide se-
quence but more likely on secondary structure of RNA (26).
Chao et al. further demonstrated that HDAg binds only to
the rod structure of HDV RNA (8), which is generated by
intramolecular base pairing (4, 38). However, a simple
double-stranded RNA structure derived from an unrelated
virus did not bind to HDAg (26), suggesting that some RNA
sequence specificity is also required for the protein-RNA
interaction. Furthermore, we have demonstrated that a small
RNA fragment (110 nucleotides) containing the ribozyme
domain of HDV genomic RNA can also bind to HDAg
(unpublished observation). This fragment does not form the
rod structure but forms a multiple stem-and-loop structure
(42). These results suggest that HDAg might recognize a
double-stranded RNA structure unique to HDV RNA. Con-
ceivably the two ARM-like sequences may bind to different
RNA strands or different regions of such an RNA structure,
thus explaining the requirement for a spacer sequence. The
precise RNA structure of the HDAg-binding sites will re-
quire additional studies.
HDV RNA replication requires a trans-acting function of
HDAg (22), although the precise role of HDAg is not clear.
A previous study suggests that HDAg is required for the
nuclear transport of HDV RNA but not directly involved in
RNA transcription per se (28). However, this interpretation
cannot explain the failure of large HDAg to trans activate
HDV RNA replication since both large and small HDAgs are
transported to the nuclei (44). Conceivably, HDAg may
serve as a transcription factor to enhance the efficiency of
HDV RNA replication. The result presented in this report
showed that the RNA-binding activity of HDAg is required
for its trans-activating activity, suggesting that HDAg has to
bind to HDV RNA to fulfill whatever role HDAg plays in
HDV RNA replication. However, the binding of HDAg to
HDV RNA is not sufficient for HDV RNA replication, since
both the large and small HDAgs bind to HDV RNA at equal
efficiency (20); yet only the small one can trans-activate
RNA replication while the large one inhibits it (7, 14, 22).
Conceivably, HDAg binds to RNA, allowing other func-
tional domains of HDAg to interact with components of the
transcriptional machinery. This interaction may be possible
only with the small HDAg. This possible mechanism of
action of HDAg is similar to that of several other RNA-
binding proteins which contain an ARM-like sequence and
play regulatory roles in transcription. For example, bacterio-
phage lambda N protein, when it binds to the nut site, may
engage RNA polymerase and modify it in a way to prevent
termination (2, 19). Also, the tat protein of HIV-1 increases
transcription processivity through interaction with the TAR
element (24). Both of these proteins recognize specific RNA
sequences through a single ARM (25). HDAg may use a
similar mechanism to redirect host cell RNA polymerase for
HDV RNA replication.
Several functional domains have been identified in HDAg
(Fig. 7). The nuclear localization signal (NLS) of HDAg
directs HDV RNA into the nuclei (44) so that RNA replica-
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leucine-zipper sequence permits HDAg oligomerization and
is also required for RNA replication (43). It appears that
HDAg forms an oligomer to participate in RNA replication;
however, oligomerization of HDAg is not required for its
RNA binding, since the middle domain of HDAg, without
the coiled-coil sequence, is sufficient for RNA binding (26).
Finally, the C-terminal 19 amino acids of the large HDAg
have an isoprenylation site (15) and probably contain the
sequences (packaging-associated sequences) required for the
packaging of HDV RNA during the assembly of HDV
particles (5, 33). The incorporation of HDV RNA into virus
particles most likely requires the RNA-binding activity of
HDAg as well. Indeed, HDV RNA and HDAg have been
shown to form a complex inside the virion particles (26).
Thus, HDAg-HDV RNA binding is required not only for
RNA replication but also for assembly of infectious virus
particles. It should be noted that some of the mutant HDAgs
(A2' and D1-2) retained a residual amount of RNA-binding
activity and yet no HDV RNA replication could be detected
when they were cotransfected with the mutant HDV dimer.
Thus, the region containing the RNA-binding motifs may
have other activities as well. Sequence analysis suggests that
there is a helix-loop-helix structure between the two ARM-
like sequences (data not shown). Conceivably, the mutations
in the ARM sequences may also affect this and other
neighboring structures. This possibility would explain the
total lack of the trans-activating activity of mutant D1-2,
which had deleted the spacer sequence and thus, the helix-
loop-helix structure. The properties of these additional se-
quences will require further studies.
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